ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. by Rizzato, C, Campa, D, Pezzilli, R, Soucek, P, Greenhalf, W, Capurso, G, Talar-Wojnarowska, R, Heller, A, Jamroziak, K, Khaw, K, Key, T, Bambi, F, Landi, S, Mohelnikova-Duchonova, B, Vodickova, L, Büchler, M, Bugert, P, Vodicka, P, Neoptolemos, J, Werner, J, Hoheisel, J, Bauer, A, Giese, N, Canzian, F

Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. by Campa, D, Rizzato, C, Bauer, A, Werner, J, Capurso, G, Costello, E, Talar-Wojnarowska, R, Jamroziak, K, Pezzilli, R, Gazouli, M, Khaw, K, Key, T, Bambi, F, Mohelnikova-Duchonova, B, Heller, A, Landi, S, Vodickova, L, Theodoropoulos, G, Bugert, P, Vodicka, P, Hoheisel, J, Delle Fave, G, Neoptolemos, J, Soucek, P, Büchler, M

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. by Campa, D, Pastore, M, Gentiluomo, M, Talar-Wojnarowska, R, Kupcinskas, J, Malecka-Panas, E, Neoptolemos, J, Niesen, W, Vodicka, P, Delle Fave, G, Bas Bueno-de-Mesquita, H, Gazouli, M, Pacetti, P, Di Leo, M, Ito, H, Klüter, H, Soucek, P, Corbo, V, Yamao, K, Hosono, S, Kaaks, R, Vashist, Y, Gioffreda, D, Strobel, O, Shimizu, Y, Dijk, F, Andriulli, A, Ivanauskas, A, Bugert, P, Tavano, F, Vodickova, L, Federico Zambon, C, Lovecek, M, Landi, S, Key, T, Boggi, U, Pezzilli, R, Jamroziak, K, Mohelnikova-Duchonova, B, Mambrini, A, Bambi, F, Busch, O, Pazienza, V, Valente, R, Theodoropoulos, G, Hackert, T, Capurso, G, Martina Cavestro, G, Pasquali, C, Basso, D, Sperti, C, Matsuo, K, Büchler, M, Khaw, K, Izbicki, J, Costello, E, Katzke, V, Michalski, C, Stepien, A, Rizzato, C, Canzian, F